Cargando…

Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions

PURPOSE: The clinical relevance of different time-to-deterioration (TTD) definitions for patient-reported outcomes were explored. METHODS: TTD definitions differing by reference score and deterioration event were used to analyse data from the phase 3 FLAURA trial of first-line osimertinib versus erl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walding, Andrew, Skaltsa, Konstantina, Casamayor, Montserrat, Rydén, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250481/ https://www.ncbi.nlm.nih.gov/pubmed/35099678 http://dx.doi.org/10.1007/s11136-022-03088-0

Ejemplares similares

Correction to: Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions
por: Walding, Andrew, et al.
Publicado: (2022)

How patients being treated for non-small cell lung cancer value treatment benefit despite side effects
por: Martin, Mona L., et al.
Publicado: (2021)

Implementation of patient reported outcomes in definitive chemoradiation for non-small cell lung cancer
por: Vogel, Jennifer, et al.
Publicado: (2020)

Patient-reported outcome measures in definitive chemoradiation for non-small cell lung cancer
por: Voong, Khinh Ranh, et al.
Publicado: (2020)

What is the Definition of Cure in Non-small Cell Lung Cancer?
por: Morgan, Helen, et al.
Publicado: (2021)

Exploring Neurocognitive Deterioration in Alzheimer’s Disease
por: Franzoni, Ferdinando, et al.
Publicado: (2023)

Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA
por: Tsuboi, Masahiro, et al.
Publicado: (2021)

Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer
por: Huang, Dingzhi, et al.
Publicado: (2023)

Polymorphisms of Homologous Recombination Genes and Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated with Definitive Radiotherapy
por: Yin, Ming, et al.
Publicado: (2011)

Clinical Outcomes of Stereotactic Ablative Radiotherapy for All Stages of Non-Small Cell Lung Cancer; Definitive versus Consolidative
por: Kim, Hakyoung, et al.
Publicado: (2022)

Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer
por: Hamada, Akira, et al.
Publicado: (2021)

Target volume definition for staple line recurrences of non-small cell lung cancer
por: Nuzhat, Jan, et al.
Publicado: (2021)

Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types
por: Hofheinz, Ralf-Dieter, et al.
Publicado: (2021)

Willingness to report treatment-related symptoms of immunotherapy among patients with non-small cell lung cancer
por: Martin, Mona L., et al.
Publicado: (2021)

Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy
por: Kim, Hakyoung, et al.
Publicado: (2019)

Exploration of lung mycobiome in the patients with non-small-cell lung cancer
por: Zhao, Yiming, et al.
Publicado: (2023)

Case Report: Termination of unplanned pregnancy led to rapid deterioration of non-small-cell lung cancer during osimertinib treatment
por: Ma, Qizhi, et al.
Publicado: (2023)

Sex Differences and Adverse Effects between Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer
por: Tsiouda, Theodora, et al.
Publicado: (2020)

Spontaneous regressions in non-small cell lung cancer with different clinical outcomes
por: Yamamoto, Masaki, et al.
Publicado: (2022)

Endobronchial brachytherapy as definitive treatment for endobronchial metastasis after surgery of non-small cell lung cancer
por: Ito, Atsushi, et al.
Publicado: (2021)

Performance-Status Deterioration during Sequential Chemo-Radiotherapy as a Predictive Factor in Locally Advanced Non-Small Cell Lung Cancer
por: Olszyna-Serementa, Marta, et al.
Publicado: (2023)

Adjusting Overall Survival Estimates after Treatment Switching: a Case Study in Metastatic Castration-Resistant Prostate Cancer
por: Skaltsa, Konstantina, et al.
Publicado: (2016)

Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer
por: Mahajan, Abhishek, et al.
Publicado: (2023)

A Bio-Guided Screening for Antioxidant, Anti-Inflammatory and Hypolipidemic Potential Supported by Non-Targeted Metabolomic Analysis of Crepis spp.
por: Barda, Christina, et al.
Publicado: (2022)

Fluorodeoxyglucose positron-emission tomography ratio in non-small cell lung cancer patients treated with definitive radiotherapy
por: Kang, Hyun-Cheol, et al.
Publicado: (2013)

Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer
por: Rajpara, Raj S, et al.
Publicado: (2014)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer
por: Fleckenstein, Jochen, et al.
Publicado: (2016)

Screening with the double surprise question to predict deterioration and death: an explorative study
por: Veldhoven, C. M. M., et al.
Publicado: (2019)

PNS250 How to Deal with COVID-19-Related Intercurrent Events on Trial Estimands for Patient-Reported Outcomes (PRO) Objectives
por: Skaltsa, K., et al.
Publicado: (2020)

Gender Differences in the Recurrence Timing of Patients Undergoing Resection for Non-Small Cell Lung Cancer
por: Watanabe, Katsuya, et al.
Publicado: (2018)

Time to revisit the definition and clinical criteria for anaphylaxis?
por: Turner, Paul J., et al.
Publicado: (2019)

Skin autofluorescence: early sign of lung function deterioration?
por: Wouters, Emiel F.M., et al.
Publicado: (2020)

Deterioration of lung function and its association with eosinophil count
por: Rajanayagam, Bama, et al.
Publicado: (2023)

An Inventory Model for Deteriorating Drugs with Stochastic Lead Time
por: Li, Jian, et al.
Publicado: (2018)

The manifold definitions of time
por: Oestreicher, Christian
Publicado: (2012)

Real-Time Definition of Non-Randomness in the Distribution of Genomic Events
por: Abel, Ulrich, et al.
Publicado: (2007)

Targeted literature review of the global burden of gastric cancer
por: Casamayor, Montserrat, et al.
Publicado: (2018)

Definitive radiotherapy with or without chemotherapy for clinical stage T4N0-1 non-small cell lung cancer
por: Kim, Yeon Joo, et al.
Publicado: (2015)

Narrative review of the emerging role of molecular biomarkers in guiding the definitive management of unresectable non-small cell lung cancer
por: Singhi, Eric K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0d4shsu1srik23oormjuis12iu